← FDA DRUG APPROVALS

FDA ANDA · ANDA063017

CEFADROXIL

Sponsor: PUREPAC PHARM

APPLICATION
ANDA063017
TYPE
ANDA
ORIGINAL APPROVAL
1989-01-05
LATEST ACTION
1992-08-28
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CEFADROXILDiscontinued
CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 500MG BASE · CAPSULE · ORAL

Approval history

1992-08-28Labeling · Supplement 5AP
1992-04-06Labeling · Supplement 3AP
1992-02-03Labeling · Supplement 2AP
1989-01-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →